Skip to content

Drug interactions

Alpelisib + Rolapitant

Severity: Moderate

Alpelisib and Rolapitant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rolapitant inhibits BCRP, and alpelisib is a BCRP substrate, so alpelisib exposure may increase.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to see why Alpelisib and Rolapitant interact, what to do about it, and the sources.

  • Mechanism of action
  • Clinical management
  • Evidence level

Try Pro+ free for 14 days on the web. No card needed.

Drug class

Alpelisib
Oncology
Rolapitant
Gastrointestinal Tract

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in